日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Post-surgery level of circulating DNA in stage III colon cancer patients: Impact on the reliability of minimal residual disease detection

III期结肠癌患者术后循环DNA水平:对微小残留病灶检测可靠性的影响

Kudriavtsev, Andrei; Daoud, Saidi; Muñoz, Catalina Isabel Cofre; Mirandola, Alexia; Pisareva, Ekaterina; Ruiz, Javier Gonzalo; Macagno, Marco; Gonzalez, Nadia Saoudi; Crapez, Evelyne; Ychou, Marc; Soler, Ramon Salazar; Fenocchio, Elisabetta; Calotti, Paula X Fernandez; Mazard, Thibault; Vivas, Cristina Santos; Elez, Elena; Di Nicolantonio, Federica; Thierry, Alain R

The BEVATOMOX phase II trial: raltitrexed/oxaliplatin/bevacizumab vs mFOLFOX6/bevacizumab in 2nd-line metastatic colorectal cancer

BEVATOMOX II期试验:雷替曲塞/奥沙利铂/贝伐单抗对比mFOLFOX6/贝伐单抗治疗二线转移性结直肠癌

Samalin, Emmanuelle; Senellart, Hélène; Thezenas, Simon; Jacquot, Stéphane; Ellis, Stephen; Akouz, Faiza Khemissa; Fiess, Catherine; Ramdani, Mohamed; Portales, Fabienne; Assenat, Eric; Ychou, Marc; Mineur, Laurent; Mazard, Thibault

Combined Analyses of Circulating Tumor DNA and Immunoscore in Patients With Stage III Colon Cancer: A Post Hoc Analysis of the PRODIGE-GERCOR IDEA-France/HORG-IDEA-Greece Trials

对 III 期结肠癌患者循环肿瘤 DNA 和免疫评分的联合分析:PRODIGE-GERCOR IDEA-France/HORG-IDEA-Greece 试验的事后分析

Taieb, Julien; Souglakos, John; Boukovinas, Ioannis; Falcoz, Antoine; Pages, Franck; Messaritakis, Ippokratis; Bennouna, Jaafar; Artru, Pascal; Louvet, Christophe; Lepere, Celine; Emile, Jean Francois; Bouche, Olivier; Mazard, Thibault; Vernerey, Dewi; Vogiatzoglou, Konstantinos; Tzardi, Maria; Sharma, Shruti; Liu, Minetta C; Sethi, Himanshu; André, Thierry; Galon, Jérome; Laurent-Puig, Pierre

Impact of Lean Body Mass-Based Oxaliplatin Dose Calculation on Neurotoxicity in Adjuvant Treatment of Stage III Colon Cancer: Results of the Phase II Randomized LEANOX Trial

基于瘦体重的奥沙利铂剂量计算对III期结肠癌辅助治疗中神经毒性的影响:II期随机LEANAX试验结果

Assenat, Eric; Ben Abdelghani, Meher; Gourgou, Sophie; Perrier, Hervé; Akouz, Faiza Khemissa; Desgrippes, Romain; Galais, Marie-Pierre; Janiszewski, Chloé; Mazard, Thibault; Rinaldi, Yves; Lepage, Côme; Tetreau, Raphael; Senesse, Pierre

Prognostic Models From Transcriptomic Signatures of the Tumor Microenvironment and Cell Cycle in Stage III Colon Cancer From PETACC-8 and IDEA-France Trials

基于PETACC-8和IDEA-France试验中III期结肠癌肿瘤微环境和细胞周期转录组特征的预后模型

Gallois, Claire; Sroussi, Marine; André, Thierry; Mouillet-Richard, Sophie; Agueeff, Natacha; Mulot, Claire; Vernerey, Dewi; Louvet, Christophe; Bachet, Jean-Baptiste; Dourthe, Louis-Marie; Mazard, Thibault; Jary, Marine; Coutzac, Clélia; Lecaille, Cédric; Tabernero, Josep; Van Laethem, Jean-Luc; Lepage, Côme; Emile, Jean-François; de Reyniès, Aurélien; Taieb, Julien; Laurent-Puig, Pierre

Early treatment discontinuation in patients with deficient mismatch repair or microsatellite instability high metastatic colorectal cancer receiving immune checkpoint inhibitors

对于错配修复缺陷或微卫星不稳定性高、转移性结直肠癌且正在接受免疫检查点抑制剂治疗的患者,应尽早停止治疗。

Taieb, Julien; Ambrosini, Margherita; Alouani, Emily; Lonardi, Sara; Sinicrope, Frank A; Decraecker, Marie; Boileve, Alice; Hafliger, Emilie; Mazard, Thibault; Pernot, Simon; Parent, Pauline; Ros, Javier; Overman, Michael J; Jayachandran, Priya; Nasca, Vincenzo; Salvatore, Lisa; Guimbaud, Rosine; Cremolini, Chiara; Tougeron, David; Pietrantonio, Filippo

Efficacy of immunotherapy in gastrointestinal (GI) tumors with mismatch repair deficient (MMRd) unusual phenotype: an AGEO real-world study

免疫疗法治疗错配修复缺陷(MMRd)异常表型胃肠道肿瘤的疗效:一项AGEO真实世界研究

Alouani, Emily; Taieb, Julien; Tougeron, David; Roces, Guillaume; Hollebecque, Antoine; Parent, Pauline; Pernot, Simon; Sinicrope, Frank A; Hautefeuille, Vincent; Ben-Abdelghani, Meher; Dutherage, Marie; Cohen, Romain; Hafliger, Emilie; Sclafani, Francesco; Muller, Marie; Perkins, Géraldine; Masson, Thérèse; Aparicio, Thomas; Coutzac, Clélia; Mazard, Thibault; Decraecker, Marie; Jaffrelot, Marion; Guimbaud, Rosine; Selves, Janick

Interplay between sarcopenia, GDF-15, and the efficacy of nivolumab plus ipilimumab in patients with mismatch repair deficient metastatic colorectal cancer: final survival analysis of the phase II GERCOR NIPICOL study.

肌少症、GDF-15 与 nivolumab 加 ipilimumab 治疗错配修复缺陷型转移性结直肠癌患者的疗效之间的相互作用:II 期 GERCOR NIPICOL 研究的最终生存分析

Depotte Leonard, Nay Paula, Borg Christophe, Meurisse Aurélia, Henriques Julie, Bennouna Jaafar, De La Fouchardière Christelle, Tougeron David, Mazard Thibault, Chibaudel Benoist, Tournigand Christophe, Vernerey Dewi, Pigneur Frédéric, Andre Thierry, Cohen Romain

Regorafenib plus modified gemcitabine-oxaliplatin in patients with advanced biliary tract cancer. The randomized phase Ib/II BREGO study

瑞戈非尼联合改良吉西他滨-奥沙利铂治疗晚期胆道癌患者。随机Ib/II期BREGO研究

Blanc, Jean-Frédéric; Bouattour, Mohamed; Gauthier, Ludovic; Deshayes, Emmanuel; Guillemard, Sophie; Touchefeu, Yann; Portales, Fabienne; Borg, Christophe; Harguem, Lobna; Guimbaud, Rosine; Mineur, Laurent; Ychou, Marc; Mazard, Thibault; Assenat, Eric

Efficacy and safety of the combination of encorafenib/cetuximab with or without binimetinib in patients with BRAF V600E-mutated metastatic colorectal cancer: an AGEO real-world multicenter study

恩考拉非尼/西妥昔单抗联合或不联合比美替尼治疗BRAF V600E突变转移性结直肠癌患者的疗效和安全性:一项AGEO真实世界多中心研究

Gallois, C; Bergen, E S; Auclin, É; Pernot, S; Higué, J; Trouilloud, I; Touchefeu, Y; Turpin, A; Mazard, T; Sartore-Bianchi, A; Prenen, H; Alberti, A; Pilla, L; Cuissy, S; Wookey, V; Perret, A; Melchior, C; Artru, P; Dubreuil, O; Drouillard, A; Doat, S; Lavolé, J; Basile, D; Perkins, G; Jary, M; Stintzing, S; Ros, J; Tougeron, D; Taieb, J